sar
coronaviru
sar
cov
etiolog
agent
respons
pandem
sar
develop
revers
genet
model
character
pathway
replic
pathogenesi
viru
renilla
luciferas
use
report
gene
insert
backbon
infecti
clone
sarscov
replac
orf
sar
wtluc
believ
apoptot
effect
host
cell
subsequ
measur
impact
transcript
regulatori
sequenc
tr
gene
express
either
two
three
mutat
introduc
orf
tr
hexanucleotid
site
luciferas
cassett
sar
sar
respect
figur
recombin
virus
three
luciferas
construct
isol
shown
stabli
maintain
renilla
luciferas
gene
express
subgenom
mrna
encod
luciferas
growth
kinet
three
construct
similar
suggest
tr
mutat
effect
efficaci
viru
replic
howev
western
blot
analysi
detect
luciferas
protein
sar
wtluc
construct
detect
express
luciferas
protein
cell
infect
recombin
virus
likewis
northern
blot
analysi
exhibit
sever
decreas
amount
subgenom
luciferas
mrna
cell
infect
two
mutant
construct
data
shown
combin
result
effect
demonstr
tr
mutat
attenu
viru
abil
effici
produc
translat
subgenom
mrna
analysi
verifi
util
dualglo
luciferas
assay
system
kit
promega
detect
luciferas
enzym
activ
luciferas
express
measur
rel
light
unit
rlu
decreas
almost
log
approxim
log
cell
infect
construct
respect
figur
sequenc
analysi
mutant
virus
suggest
reduc
luciferas
express
due
mechan
use
bypass
mutat
tr
region
variou
noncanon
leader
bodyjunct
identifi
surround
tr
region
subgenom
sequenc
two
mutant
construct
replicas
slippag
usag
noncanon
trslike
junction
allow
low
level
subgenom
transcript
express
luciferas
recombin
sar
wtluc
viru
also
use
measur
efficaci
put
antisar
agent
four
variou
interferon
ifn
treatment
test
abil
protect
host
cell
sar
infect
mixtur
plu
cell
seed
approxim
concentr
cell
well
plate
hour
prior
infect
hour
prior
infect
intern
unit
u
appropri
ifn
treatment
ad
whole
media
cell
infect
sar
wtluc
multipl
infect
moi
allow
incub
room
temperatur
hour
luciferas
express
measur
variou
time
point
hour
postinfect
hpi
ifn
treatment
effect
inhibit
sar
infect
least
log
synergist
effect
extrem
effect
u
decreas
luciferas
activ
log
figur
addit
ifn
treatment
synthet
chemic
compound
develop
inhibit
mpro
bind
vero
cell
seed
approxim
hour
prior
infect
describ
infect
sar
wtluc
moi
allow
incub
hour
room
temperatur
subsequ
whole
media
appropri
drug
ad
luciferas
express
assess
via
luciferas
bioassay
variou
time
point
hpi
drug
decreas
luciferas
express
least
figur
antisar
agent
use
subsequ
effect
dose
studi
vero
cell
initi
treat
manner
except
hour
infect
period
ad
well
luciferas
express
measur
hpi
exhibit
small
doserespons
decreas
luciferas
activ
log
increas
concentr
thereaft
show
enhanc
activ
almost
log
demonstr
sar
wtluc
viabl
viru
allow
studi
effect
subgenom
manipul
viru
efficaci
replic
subgenom
product
util
viru
sensit
way
evalu
viru
growth
use
luciferas
express
proxi
also
show
import
tr
region
subgenom
mrna
product
andor
translat
approach
offer
altern
plaqu
assay
analysi
test
effici
antisar
agent
dualglo
luciferas
assay
system
promega
conjunct
sar
wtluc
viru
provid
rapid
extrem
sensit
accur
highthroughput
screen
method
